TABLE 3.
Overview on Reported Dose Estimates for the Unexposed (0 Gy), Low Exposed (1.2 Gy) and Highly Exposed (3.5 Gy) Reference Samples and Their Allocation to Dose Bands Referring to Clinically Relevant Groups
| Reference dose | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 Gy |
1.2 Gy |
3.5 Gy |
|||||||
| Reported dose estimates allocated to dose categories of clinical relevance | |||||||||
| Assay | 0–1 Gy | >1–2 Gy | >2 Gy | 0–1 Gy | >1–2 Gy | >2 Gy | 0–1 Gy | >1–2 Gy | >2 Gy |
| EPR | |||||||||
| Freq | 15 | 1 | 0 | 3 | 9 | 3 | 0 | 0 | 13 |
| Percent | 93.8 | 6.3 | 0.0 | 20.0 | 60.0 | 20.0 | 0.0 | 0.0 | 100.0 |
| LUM | |||||||||
| Freq | 23 | 0 | 0 | 4 | 14 | 3 | 0 | 0 | 21 |
| Percent | 100.0 | 0.0 | 0.0 | 19.0 | 66.7 | 14.3 | 0.0 | 0.0 | 100.0 |
| DCA | |||||||||
| Freq | 36 | 0 | 0 | 2 | 26 | 8 | 0 | 0 | 36 |
| Percent | 100.0 | 0.0 | 0.0 | 5.6 | 72.2 | 22.2 | 0.0 | 0.0 | 100.0 |
| CBMN | |||||||||
| Freq | 20 | 1 | 0 | 2 | 15 | 4 | 0 | 0 | 21 |
| Percent | 95.2 | 4.8 | 0.0 | 9.5 | 71.4 | 19.0 | 0.0 | 0.0 | 100.0 |
| FISH | |||||||||
| Freq | 6 | 1 | 0 | 0 | 4 | 3 | 0 | 0 | 7 |
| Percent | 85.7 | 14.3 | 0.0 | 0.0 | 57.1 | 42.9 | 0.0 | 0.0 | 100.0 |
| PCC | |||||||||
| Freq | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 |
| Percent | 100.00 | 0.00 | 0.00 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 100.0 |
| GE | |||||||||
| Freq | 30 | 1 | 0 | 9 | 7 | 15 | 1 | 2 | 25 |
| Percent | 96.8 | 3.2 | 0.0 | 29.0 | 22.6 | 48.4 | 3.6 | 7.1 | 89.3 |
| gH2AX | |||||||||
| Freq | 6 | 0 | 0 | 3 | 3 | 0 | 2 | 0 | 4 |
| Percent | 100.0 | 0.0 | 0.0 | 50.0 | 50.0 | 0.0 | 33.33 | 0.00 | 66.67 |
Note. The number of dose estimates (semiquantitative data are excluded) is provided as a frequency and in percent for each assay.